Depsipeptide, a histone deacetylase inhibitor for treatment of cutaneous T-cell lymphoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL LYMPHOMA & MYELOMA | 2006年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 364
页数：7
相关论文
共 50 条
  • [41] Characterization of Cyclic Hematologic Changes Observed in Patients with Cutaneous T-Cell Lymphoma (CTCL) Receiving Romidepsin, a Novel Histone Deacetylase (HDAC) Inhibitor
    Whittaker, Sean
    Kim, Ellen J.
    Prince, Miles
    Demierre, Marie France
    Giver, Cynthia
    Lonial, Sagar
    Pickarz, Richard
    Kim, Youn H.
    Nichols, Jean
    Nix, Darrell
    Bates, Susan
    BLOOD, 2009, 114 (22) : 1425 - 1425
  • [42] Minimizing the immunosuppressive effects of histone deacetylase inhibitors (HDACi): Implications for therapy of cutaneous T-cell lymphoma (CTCL)
    Anshelevich, A.
    Wysocka, M.
    Benoit, B. M.
    Rook, A. H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S51 - S51
  • [43] POPULATION PHARMACOKINETICS OF CYCLIC DEPSIPEPTIDE FK228 IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA AND RELAPSED PERIPHERAL T-CELL LYMPHOMA
    Woo, S.
    Gardner, E. R.
    Chen, X.
    Ockers, S. B.
    Baum, C. E.
    Sissung, T. M.
    Price, D. K.
    Frye, R.
    Peikarz, R. L.
    Bates, S. E.
    Figg, W. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S66 - S66
  • [44] Update on the phase II trial and correlative studies of depsipeptide in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma
    Piekarz, R
    Frye, R
    Turner, M
    Wright, J
    Leonard, J
    Allen, S
    Bates, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 202S - 202S
  • [45] Bexarotene in the treatment of cutaneous T-cell lymphoma
    Querfeldt, Christiane
    Nagelli, Lakshmi V.
    Rosen, Steven T.
    Kuzel, Timothy M.
    Guitart, Joan
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (07) : 907 - 915
  • [46] Alitretinoin in the treatment of cutaneous T-cell lymphoma
    Kaemmerer, Till
    Stadler, Pia-Charlotte
    Frommherz, Leonie Helene
    Guertler, Anne
    French, Lars Einar
    Reinholz, Markus
    CANCER MEDICINE, 2021, 10 (20): : 7071 - 7078
  • [47] CISPLATIN TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    WITMAN, G
    CADMAN, E
    BRAVERMAN, I
    CANCER TREATMENT REPORTS, 1981, 65 (9-10): : 920 - 920
  • [48] Forodesine in the treatment of cutaneous T-cell lymphoma
    Lewis, Daniel J.
    Duvic, Madeleine
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (06) : 771 - 775
  • [49] Update on treatment of cutaneous T-cell lymphoma
    Gardner, Jennifer M.
    Evans, Katherine G.
    Musiek, Amy
    Rook, Alain H.
    Kim, Ellen J.
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (02) : 131 - 137
  • [50] Genome-wide identification of alternative splicing associated with histone deacetylase inhibitor in cutaneous T-cell lymphomas
    Yu, Shirong
    Zhang, Jingzhan
    Ding, Yuan
    Kang, Xiaojing
    Pu, Xiongming
    FRONTIERS IN GENETICS, 2022, 13
12345